Company intelligence / Profile preview

AESKU.BION

Des Plaines, Illinois, USAaesku.com ↗

Ownership: Private
Development stage: Commercial

Overview

AESKU.BION specializes in manufacturing high-quality immunofluorescence assay products for clinical laboratories in immunology, virology, and microbiology. The company is FDA registered and ISO 13485 certified. It was acquired by AESKU.GROUP in August 2019 to expand the group’s IFA product menu and production operations[1][5][6]. Their portfolio includes commercialized diagnostic kits used globally.

Modalities: Immunofluorescence assay (IFA)Enzyme-linked immunosorbent assay (ELISA)Blot test
Industry: Protein Biomarker Diagnostics

Partnerships

MBL International/JSR Life Sciences (pre-acquisition)Other partnerships not specified post-acquisition by AESKU.GROUP.

Beyond the preview

Go deeper on AESKU.BION.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AESKU.BION.

Explore the full profile